Protocol ID

Official Title

Principal Investigator

Lead CRC

Disease Site

Phase

A011202

ClinicalTrials.gov #

NCT01901094

A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Dr. Sharad Ghamande

Inquiries

Breast

III 

MK7339-009

ClinicalTrials.gov #

NCT04191135

An Open-label, Randomized, Phase 2/3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab in Participants With Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC)

Dr. Allen Krutchik

Joanne Huff

Breast

II/III

NRG-BR003

ClinicalTrials.gov #

NCT02488967

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Dr. Sharad Ghamande

Kelly Adams

Breast

III

SGNTUC-016

ClinicalTrials.gov #

NCT03975647 

Randomized, Double-Blind, Phase 3 Study of Tucatinib or Placebo in Combination with Ado-Trastuzumab Emtansine (T DM1) for Subjects with Unresectable Locally-Advanced or Metastatic HER2+ Breast Cancer

Dr. Allen Krutchik

Joanne Huff

Breast

III

WCI4472-18

ClinicalTrials.gov #

NCT03691493 

A Phase II Multi-institutional Study of Concurrent Radiotherapy, Palbociclib, and Hormone Therapy for Treatment of Bone Metastasis in Breast Cancer Patients

Dr. Catherine Ferguson

Joanne Huff

Breast

II